Penetratin-modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration

Ying Ge,Anan Zhang,Rong Sun,Jiawen Xu,Tian Yin,Haibing He,Jingxin Gou,Jun Kong,Yu Zhang,Xing Tang
DOI: https://doi.org/10.1080/17425247.2020.1735348
2020-03-09
Expert Opinion on Drug Delivery
Abstract:<span><b>Background</b>: Lutein is the primary macular pigment with an favorable effect on the treatment of age-related macular degeneration (AMD). However, the poor water solubility of lutein hinders its absorption and delivery. In this study, a penetratin-modified lutein nanoemulsion <i>in-situ</i> gel (GEL) was prepared for the treatment of AMD.<b>Methods</b>: A nanoemulsion (NE) was prepared and modified with penetratin (P-NE) to improve the penetration. The effect of penetratin was evaluated by cell uptake and intraocular distribution assays. A dry AMD model was induced using NaIO<sub>3</sub>, and the therapeutic effect was evaluated by electroretinography, the number of apoptosis cells and the reactive oxygen species (ROS) level.<b>Results</b>: Lutein showed a good ability to protect ARPE-19 from the damage of H<sub>2</sub>O<sub>2</sub> and the uptake rate of P-NE was significantly higher than NE. In the efficacy experiments, the structure of retina was significantly improved after treatment, the apoptosis rate decreased from 31.98% to 2.05%, and the level of ROS was significantly decreased (<i>p</i> &lt; 0.0001).<b>Conclusions</b>: With the aid of penetratin, lutein could be delivered to the retina effectively. The P-NE GEL could evidently inhibit the apoptosis and ROS, demonstrating that the P-NE GEL has a good application prospect in the treatment of AMD.</span>
pharmacology & pharmacy
What problem does this paper attempt to address?